KLOW
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg
≥ 99.2% · Lyophilized powder
In stock
- Purity
- ≥ 99.2%
- Form
- Lyophilized powder
- Vial size
- 80 mg
- Lot
- 0480
- HPLC-verified purity — ≥ 99.2%
- North American manufactured
- Shipped from Ontario
FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN CONSUMPTION. Sold for laboratory and research purposes only.
What's in the vial.
- Compound
- KLOW
- Lane
- Stacks
- Composition
- GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg
- Available sizes
- 80 mg
- Storage
- Cold, away from light
Co-supplied preparation of GHK-Cu, BPC-157, TB-500 and KPV. Supplied as lyophilized powder for laboratory research use only. Independently assayed for purity and identity.
Shipping, pricing and ordering questions for Canadian labs are answered on KLOW in Canada.
KLOW.
A four-compound preparation adding KPV — a tripeptide fragment of α-MSH — to the GLOW combination.
Research context
Extends the GLOW preparation with an additional immunomodulatory-research tripeptide.
Handling & storage
Reconstitute with bacteriostatic or sterile water. Protect from light — copper complexes are photosensitive. Store lyophilized powder at −20 °C.
Note
Descriptions are provided for laboratory reference only and describe the compound and the research field in which it appears. Nothing here is a recommendation, protocol, or statement of effect.
